ReviewOrphanet journal of rare diseases2021

The multi-domain responder index: a novel analysis tool to capture a broader assessment of clinical benefit in heterogeneous complex rare diseases.

P K Tandon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.